Recently Government has revised guidelines for the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical devices.
The Medical Device sector in India suffers from a considerable cost of manufacturing disability due to competing economies, besides lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of power, limited design capabilities and low focus on research and development (R&D) and skill development etc. Thus, Department of pharmaceuticals was felt a need for a mechanism to compensate for this manufacturing disability in order to ensure a level playing field for the domestic manufacturers of medical devices.
In July 2020, Government of India has come out with a scheme called Production Linked Incentive Scheme (PLI) for promoting domestic manufacturing of Medical Devices to compensate for the manufacturing disability in selected segments of medical devices.
A committee, headed by the CEO, Andhra Pradesh MedTech Zone Ltd, constituted by the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has provided technical inputs to prepare the guidelines. These guidelines have been prepared after detailed consultations with the industry and other relevant stakeholders.
